| Literature DB >> 34284535 |
Eray Yildiz, Fatih Çölkesen, Şevket Arslan, Recep Evcen, Filiz Sadi Aykan, Mehmet Kilinç, Gökhan Aytekin.
Abstract
BACKGROUND: Although allergic diseases are generally considered to be diseases of childhood and youth, the first symptoms of allergic diseases can be seen in old age sometimes. The aim of this study was to determine the prevalence and characteristics of allergic diseases in the elderly population admitted to the allergy unit on an outpatient basis.Entities:
Keywords: Elderly; allergic diseases; allergic rhinitis; drug hypersensitivity reactions; hymenoptera venom allergy; anaphylaxis
Year: 2021 PMID: 34284535 PMCID: PMC8742485 DOI: 10.3906/sag-2104-55
Source DB: PubMed Journal: Turk J Med Sci ISSN: 1300-0144 Impact factor: 0.973
General characteristics of patients aged ≥ 65 years.
| n (%) | |
|---|---|
| Total | 1272 |
| Age, median (min-max) | 70 (65–97) |
| Sex | |
| Female | 704 (55.3) |
| Male | 568 (44.7) |
| Atopy | 193 (15.2) |
| Comorbidity | 1006 (79.1) |
| Cardiovascular diseases | 812 (63.8) |
| Diabetes mellitus | 323 (25.4) |
| Respiratory diseases | 170 (13.4) |
| Thyroid diseases | 110 (8.6) |
| Renal-urinary system diseases | 96 (7.5) |
| Neuropsychiatric diseases | 88 (6.9) |
| Malignant diseases | 49 (3.9) |
| Rheumatological diseases | 28 (2.2) |
| Gastrointestinal-liver diseases | 27 (2.1) |
| Autoimmune diseases | 7 (0.6) |
| Presentation forms | |
| Cutaneous symptoms | 887 (69.8) |
| Rhinitis symptoms | 155 (12.2) |
| Respiratory symptoms | 144 (11.3) |
| Anaphylaxis | 65 (5.1) |
| Conjunctivitis symptoms | 21 (1.6) |
Characteristics of patients presenting with cutaneous symptoms.
| n (%) | |
|---|---|
| Total | 887 (69.8) |
| Urticaria, without angioedema1 | 427 (48.1) |
| Idiopathic | 327 (76.6) |
| Drug | 87 (20.4) |
| Antibiotics | 27 (6.3) |
| NSAIDs | 25 (5.9) |
| Others 2 | 35 (8.2) |
| Food | 12 (2.8) |
| Venom | 1 (0.2) |
| Urticaria, with angioedema1 | 73 (8.2) |
| Idiopathic | 48 (65.8) |
| Drug | 20 (27.4) |
| Antibiotics | 13 (17.8) |
| NSAIDs | 5 (6.8) |
| Others | 2 (2.8) |
| Food | 3 (4.1) |
| Venom | 2 (2.7) |
| Angioedema, without urticaria3 | 58 (6.5) |
| ACE inhibitors4 | 35 (60.4) |
| Idiopathic | 9 (15.5) |
| NSAIDs | 8 (13.9) |
| Other drugs | 3 (5.1) |
| Food | 1 (1.7) |
| Venom | 1 (1.7) |
| Acquired | 1 (1.7) |
| Xerosis | 137 (15.4) |
| Systemic diseases5 | 89 (10) |
| Allergic contact dermatitis6 | 39 (4.5) |
| Atopic dermatitis7 | 13 (1.5) |
| Other skin diseases8 | 51 (5.8) |
NSAIDs: Nonsteroidal antiinflammatory drugs, ACE: Angiotensin converting enzyme.1 Sex, female (n = 295, 59%), male (n = 205, 41%), atopy (n = 82, 16.4%), comorbidity (n = 398, 79.6%).2 Cardiovascular drugs (mainly ACE inhibitors and beta-blockers) (n = 8), chemotherapeutics (n = 8), allopurinol (n = 5), local anesthetics (n = 4), contrast agents (n = 3), proton pump inhibitors (n = 2), insulin (n = 2), methimazole (n = 1), pregabalin (n = 1), infliximab (n =1)3 Sex, female (n = 32, 55%), male (n = 26, 45%), atopy (n = 82, 16.4%), comorbidity (n = 12, 21%).4 ACE inhibitor-induced angioedema; 4.7% (n = 35/738). Sex, female (n = 20, 57%), male (n = 15, 43%), atopy (n = 7, 35%), comorbidity (n = 35, 100%).5 Systemic diseases; liver diseases, kidney diseases, hematologic diseases, endocrine disorders, neurologic diseases, paraneoplasic pruritus, infectious diseases.6 Ten patients who developed gingivitis and stomatitis > 24 h after dental prosthesis application were accepted as contact allergy to dental metals. Sex, female (n = 20, 51%), male (n = 19, 49%), atopy (n = 3, 7.7%), comorbidity (n = 29, 74%).7 Sex, male: 77% (n = 10), female: 23% (n = 3), atopy (n = 4, 31%), comorbidity (n = 11, 85%).8 Other skin diseases; all skin diseases other than the above diagnoses (most common scabies and bullous pemphigoid).
Characteristics of patients with drug hypersensitivity reactions.
| n (%) | |
|---|---|
| Total | 175 (13.7) |
| Sex | |
| Female | 99 (57) |
| Male | 76 (43) |
| Atopy | 46 (26) |
| Comorbidity | 149 (85) |
| Immediate type | 163 (93.1) |
| Urticaria, without angioedema | 87 (53.4) |
| Antibiotics1 | 27 (31) |
| NSAIDs | 25 (28.7) |
| Cardiovascular drugs | 8 (9.3) |
| Chemotherapeutics | 8 (9.3) |
| Allopurinol | 5 (5.7) |
| Local anesthetics | 4 (4.6) |
| Contrast agents | 3 (3.4) |
| Others | 7 (8.0) |
| Anaphylaxis | 45 (27.6) |
| NSAIDs | 21 (46.7) |
| Antibiotics2 | 19 (42.2) |
| Others3 | 5 (11.1) |
| Urticaria, with angioedema | 20 (12.3) |
| NSAIDs | 13 (65) |
| Antibiotics1 | 5 (25) |
| Others | 2 (10) |
| Angioedema, without urticaria | 11 (6.7) |
| NSAIDs | 8 (72.7) |
| Others | 3 (27.3) |
| Delayed type | 12 (6.9) |
| SJS/TEN | 6 (50) |
| Allopurinol | 2 (33.2) |
| Carbamazepine | 2 (33.2) |
| NSAIDs | 1 (16.6) |
| Antibiotics | 1 (16.6) |
| DRESS | 3 (25) |
| Allopurinol | 2 (66.7) |
| Carbamazepine | 1 (33.3) |
| Allergic contact dermatitis | 2 (16.7) |
| NSAIDs | 2 (100) |
| FDE | 1 (8.3) |
| NSAIDs | 1 (100) |
NSAIDs: Nonsteroidal antiinflammatory drugs, SJS: Stevens–Johnson syndrome, TEN: Toxic epidermal necrolysis, DRESS: Drug reaction with eosinophilia and systemic syndrome, FDE: Fixed drug eruption.1 Beta lactams (54%), quinolones (25%).2 Beta lactams (84.2%).3 Proton pump inhibitors (n = 2), local anesthetics (n = 1), vitamin B12 (n = 1), ranitidine (n = 1).
Characteristics of patients presenting with rhinitis and respiratory symptoms.
| n (%) | |
|---|---|
| Rhinitis symptoms | |
| Total | 155 (12.2) |
| Nonallergic rhinitis | 107 (8.4) |
| Allergic rhinitis | 48 (3.8) |
| Age | |
| 65–74 years | 44 (91) |
| ≥ 75 years | 4 (9) |
| Sex | |
| Male | 25 (52) |
| Female | 23 (48) |
| Comorbidity | 35 (73) |
| Allergens | |
| Pollens1 | 38 (81.4) |
| Mites | 30 (62.6) |
| Blatella germanica | 7 (14.6) |
| Cat | 4 (8.3) |
| Alternaria alternata | 4 (8.3) |
| Latex | 1 (2.1) |
| Respiratory symptoms | |
| Total | 144 (11.4) |
| Asthma | 71 (5.6) |
| Sex | |
| Female | 54 (76) |
| Male | 17 (24) |
| Comorbidity | 53 (75) |
| Atopy | 19 (27) |
| Spirometry | 17 (24) |
| Allergens | |
| Pollens 2 | 7 (61.6) |
| Mites | 5 (38.5) |
| Alternaria alternata | 2 (15.4) |
| Cat | 1 (7.7) |
| Other respiratory conditions | 73 (5.8) |
| ACE inhibitor associated cough | 17 (23.3) |
| Chronic obstructive pulmonary disease | 12 (16.4) |
| Gastroesophageal reflux disease | 12 (16.4) |
| Heart failure | 11 (15.1) |
| Pneumonia | 8 (11) |
| Post nasal discharge | 8 (11) |
| Others | 5 (6.8) |
ACE: Angiotensin converting enzyme.1 Weed pollens (44.7%), grass pollens (39.5%).2 Weed pollens (57%).
Characteristics of patients with anaphylaxis.
| n (%) | |
|---|---|
| Total | 65 (5.1) |
| Sex | |
| Female | 34 (52) |
| Male | 31 (48) |
| Atopy | 36 (55) |
| Comorbidity | 50 (77) |
| Drugs | 45 (69.2) |
| NSAIDs | 21 (46.7) |
| Antibiotics | 19 (42.2) |
| Beta lactams | 16 (84.2) |
| Others | 3 (15.8) |
| Others | 5 (10.1) |
| Venom | 19 (29.2) |
| Vespula spp. | 8 (42.1) |
| Apis mellifera | 7 (36.8) |
| Apis mellifera + Vespula spp. | 4 (21.1) |
| Food | 1 (1.6) |
NSAIDs: Nonsteroidal antiinflammatory drugs.
Characteristics of patients with hymenoptera venom allergy.
| n (%) | |
|---|---|
| Total | 24 (1.9) |
| Sex | |
| Male | 20 (83) |
| Female | 4 (17) |
| Atopy | 17 (71) |
| Comorbidity | 18 (75) |
| Clinic | |
| Systemic reaction | 22 (91.7) |
| Grade I | 3 (13.6) |
| Grade II | 10 (45.5) |
| Grade III | 7 (31.8) |
| Grade IV | 2 (9.1) |
| Large local reaction | 2 (8.3) |
| Insects | |
| Vespula spp. | 11 (46) |
| Apis mellifera | 8 (33) |
| Apis mellifera + Vespula spp. | 5 (21) |
| Patients admitted to the emergency room | 19 (79) |
| Patients carrying adrenaline auto-injectors | 19 (79) |
| Patients started immunotherapy | 2 (8.5) |
| Beekeepers | 9 (37.5) |
| Tryptase | |
| > 11.4 µg/L | 2 (8.3) |
Characteristics of patients with food allergy.
| n (%) | |
|---|---|
| Total | 18 (1.4) |
| Sex | |
| Female | 11 (61) |
| Male | 7 (39) |
| Atopy | 9 (50) |
| Comorbidity | 15 (83) |
| Clinic | |
| Urticaria, without angioedema | 12 (67) |
| Urticaria, with angioedema | 2 (11) |
| Rhinitis | 2 (11) |
| Angioedema, without urticaria | 1 (5.5) |
| Anaphylaxis1 | 1 (5.5) |
| Food | |
| Peanut | 5 (33) |
| Egg | 4 (22) |
| Soy | 2 (11) |
| Apricot 2 | 1 (5.6) |
| Peach 2 | 1 (5.6) |
| Others 3 | 6 (33.5) |
1 Peanut.2 Apricot-birch and peach-mugwort cross-sensitivity.3 Hazelnut (n = 1), apple (n = 1), strawberry (n = 1), wheat flour (n = 1), fish (n = 1), lobster (n = 1).
Results of skin test in patients.
| n (%) | |
|---|---|
| Total | 110 (14) |
| Inhalant allergens | 86 (78.2) |
| Pollens | 65 (59.1) |
| Weed pollens | 35 (53.8) |
| Grass pollens | 21 (32.3) |
| Tree pollens | 9 (13.9) |
| Mites | 63 (57.3) |
| Blatella | 10 (9.1) |
| Alternaria | 9 (8.2) |
| Cat and dog epithelium | 6 (5.4) |
| Latex | 2 (1.8) |
| Food allergens | 20 (18.2) |
| Egg | 5 (4.5) |
| Peanut | 4 (3.6) |
| Soy | 4 (3.6) |
| Cocoa 1 | 3 (2.7) |
| Others | 10 (9) |
| Inhalant allergens + Food allergens | 4 (3.6) |
1 Cocoa-nickel cross-sensitivity was detected in three patients.
Logistic regression analysis results of risk factors for allergic diseases in the elderly.
| Comorbidity | Atopy | Sex | ||||
|---|---|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | |
| Urticaria, with and without angioedema | 1.059 (0.802–1.399) | 0.686 | 0.950 (0.692–1.304) | 0.752 | 0.760 (0.605–0.955) | 0.019 |
| Angioedema, without urticaria | 1.904 (0.852–4.253) | 0.116 | 1.570 (0.813–3.030) | 0.179 | 1.063 (0.621–1.820) | 0.822 |
| Allergic contact dermatitis | 0.764 (0.367–1.587) | 0.470 | 0.460 (0.140–1.510) | 0.201 | 1.168 (0.617–2.211) | 0.633 |
| Atopic dermatitis | 1.482 (0.326–6.726) | 0.610 | 2.530 (0.771–8.298) | 0.126 | 4.141 (1.134–15.120) | 0.031 |
| Drug hypersensitivity reactions | 1.631 (1.050–2.533) | 0.029 | 2.323 (1.590–3.393) | < 0.001 | 0.934 (0.677–1.288) | 0.676 |
| Allergic rhinitis | 0.705 (0.368–1.352) | 0.293 | 3.287 (1.781–6.067) | < 0.001 | 1.345 (0.755–2.396) | 0.314 |
| Asthma | 0.770 (0.443–1.338) | 0.354 | 1.729 (0.968–3.086) | 0.064 | 0.397 (0.230–0.685) | 0.001 |
| Anaphylaxis | 0.888 (0.491–1.608) | 0.696 | 8.363 (4.986–14.028) | < 0.001 | 1.126 (0.683–1.856) | 0.641 |
| Hymenoptera venom allergy | 0.802 (0.315–2.040) | 0.643 | 14.877 (6.081–36.393) | < 0.001 | 3.462 (1.097–10.933) | 0.0341 |
| Food allergy | 1.346 (0.387–4.684) | 0.640 | 5.852 (2.293–14.939) | < 0.001 | 1.280 (0.493–3.324) | 0.612 |
OR: Odds ratio, CI: Confidence interval.1 Beekeepers excluded.